Goldenwell Biotech Income Statement (2019-2025) | GWLL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue (Quarter)			0.00M	0.01M	0.00M	397.00	0.00M	0.04M		0.00M	276.00	382.00	260.00		139.00		-158.00
Cost of Revenue (Quarter)			525.00	0.01M	0.00M	188.00	0.00M	0.02M		711.00	138.00	196.00	187.00		69.00		-73.00
Gross Profit (Quarter)			581.00	0.01M	0.00M	209.00	0.00M	0.02M		711.00	138.00	186.00	73.00		70.00		-85.00		0.04M	0.03M
Operating items
Selling, General & Administrative (Quarter)	0.00M	0.05M	0.02M	0.10M	0.10M	0.03M	0.03M	0.03M	0.92M	0.03M	0.03M	0.04M	0.02M	0.03M	0.05M	0.02M	0.02M	0.03M	0.04M	0.03M
Other Operating Expenses (Quarter)		-0.09M	-0.05M		-0.25M					-0.07M
Operating Expenses (Quarter)	0.00M	-0.05M	-0.02M	0.10M	-0.15M	0.03M	0.03M	0.03M	0.92M	-0.03M	0.03M	0.04M	0.02M	0.03M	0.05M	0.02M	0.02M	0.03M	0.04M	0.03M
Operating Income (Quarter)	-625.00	0.05M	0.03M	-0.09M	-0.01M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.01M	-0.05M	-0.02M	0.07M	-0.01M	-0.00M	-0.01M
EBIT (Quarter)	-625.00	0.05M	0.03M	-0.09M	-0.01M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.01M	-0.05M	-0.02M	0.07M	-0.01M	-0.00M	-0.01M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	5.00	750.00	264.00	0.00M	0.00M	7.00	1.00
Non Operating Income (Quarter)	5.00	750.00	264.00	0.00M	0.00M	7.00	1.00
Net income details
EBT (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	0.07M	-0.03M	-0.01M	-0.01M
Profit After Tax (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	-0.03M	-0.03M	-0.01M	-0.01M
Income from Continuing Operations (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	0.07M	-0.03M	-0.01M	-0.01M
Consolidated Net Income (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	0.07M	-0.03M	-0.01M	-0.01M
Income towards Parent Company (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	0.07M	-0.03M	-0.01M	-0.01M
Net Income towards Common Stockholders (Quarter)	-0.00M	-0.05M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.03M	-0.05M	-0.02M	0.07M	-0.03M	-0.01M	-0.01M
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS (Weighted Average and Diluted) (Quarter)													0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding (Weighted Average) (Quarter)	80.00M	80.00M	91.32M	91.32M	91.32M	91.32M	91.32M	91.32M	96.43M	96.43M	96.43M	96.43M	96.43M	96.43M	96.43M	96.43M	99.00M	9.90M	9.90M	99.00M
Shares Outstanding (Diluted Average) (Quarter)													99.00M	99.00M	96.43M	96.43M	99.00M	99.00M	96.43M	96.43M
EBITDA (Quarter)	-625.00	0.05M	0.03M	-0.09M	-0.01M	-0.03M	-0.03M	-0.00M	-0.92M	-0.03M	-0.03M	-0.04M	-0.02M	-0.01M	-0.05M	-0.02M	0.07M	-0.01M	-0.00M	-0.01M
Interest Expenses (Quarter)	-39.00			258.00	-0.00M									0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M

Research Tools

Goldenwell Biotech Income Statement (2019-2025) | GWLL

Create an account

Sign In

Reset Password